Emma is one of more than 250 people who have now contacted us about addictions - gambling, but also sex and shopping - caused ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...

Could Ozempic reshape risk appetite in financial markets? Emerging research on GLP-1 drugs like semaglutide suggests they dampen dopamine-driven anticipation in the brain's reward ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions. This is a stunning gut-brain breakthrough.

What if you lost weight and didn’t care — about anything?

Work hard in the gym, stay cool under pressure. The benefits of exercise have long been recognized, from improved heart ...

The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a fundamentally new mechanism of action in more than half a century. Built on ...

However, the opioid pathway, a heavily studied physiologic pathway inextricably intertwined with behaviour and reward, rarely receives attention within psychiatric practice. Although the opioid system ...

After much talk of an economic slowdown, February brought reassuring headlines. The official unemployment rate had fallen as ...

Experts reveal if a cayenne shot is worth the burn - Cayenne shots are usually sold in 2oz bottles and made up of cayenne pepper, lemon or orange juice, ginger, maple syrup and sometimes black pepper ...